SEONGNAM, South Korea, April 7, 2025 /PRNewswire/ -- ABL Bio Inc. (KOSDAQ: 298380), a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and ...

ABL Bio Inc. (KOSDAQ: 298380), a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and neurodegenerative diseases, announced a worldwide licensing ...

GSK and ABL Bio have entered into an agreement worth over £2bn to develop new drugs for neurodegenerative diseases. The global licensing deal will allow GSK to use ABL Bio’s blood-brain barrier (BBB) ...

BetterLesson, the leader in data-driven, high-quality professional learning for K-12 educators announced the acquisition of Abl, a pioneer in equitable, rigorous, student scheduling and ...

The ABL lasted 2½ seasons but remains an important chapter in professional women's hoops history, one that included much of what today's players still want.

Significant changes are coming to ABL Space Systems.The leader of the 7-year-old startup took to social media last night to make a big announcement: The company will no longer be focusing on the ...

ABL has been competing alongside Relativity Space and Firefly to bring its rockets to market. ABL never took off. In March 2023, Relativity reached space with the Terran 1 rocket, but, due to ...

WASHINGTON — ABL Space Systems, a six-year-old launch startup, announced it is exiting the commercial launch market to focus on missile defense programs for the Pentagon.

Energy and marine consultancy ABL has signed a partnership agreement with technology start-up Satva Trust to provide its… Wednesday, June 25, 2025.

ABL Space System's RS1 rocket launches on its debut mission from the Pacific Spaceport Complex in Alaska on Jan. 10, 2023. The rocket suffered an anomaly shortly after liftoff and failed to reach ...

Scout Space’s ‘Owlet’ smallsat mission would be the third launch of ABL’s RS1 rocket by Sandra Erwin June 10, 2024 June 10, 2024 Click to share on X (Opens in new window) X ...